CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities:
Net income	$ 327	$ 508
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Amortization of deferred financing costs	227	125
Accretion of deferred loan origination fees and costs	(739)	(57)
Stock based compensation	136
Unrealized loss on derivative	398
Changes in operating assets and liabilities:
Interest receivable	(718)	(518)
Other assets	323	(24)
Due to affiliate	122	(144)
Interest payable		71
Refundable deposits	50	(200)
Accounts payable and accrued expenses	1,100	18
Net cash provided by (used in) operating activities	1,226	(221)
Investing activities:
Issuance of and fundings on loans held for investment	(56,299)	(73,147)
Principal repayment of loans held for investment	56	18
Receipt of origination fees	539	880
Net cash used in investing activities	(55,704)	(72,249)
Financing activities:
Proceeds from secured funding arrangements	55,794	47,289
Secured funding costs	(10)	(596)
Convertible notes issuance costs	171
Proceeds from issuance of Series A Convertible Preferred Stock		5,723
Proceeds from issuance of common stock		23,400
Common dividend payment	(2,317)
Net cash provided by financing activities	53,638	75,816
Change in cash and cash equivalents	(840)	3,346
Cash and cash equivalents, beginning of period	23,390	1,240
Cash and cash equivalents, end of period	22,550	4,586
Supplemental Information:
Interest paid during the period	1,128	143
Supplemental disclosure of noncash financing activities:
Dividends payable	2,317	502
Accretion of redemption premium		572
Deferred financing and offering costs		$ 332